Search by product name, CAS, target or catalog number. Press Down Arrow to reach product suggestions, Tab to move between links, and Escape to close suggestions.
MCHR1 antagonists block melanin-concentrating hormone receptor 1 (MCHR1), a G protein-coupled receptor. Melanin-concentrating hormone (MCH) is a cyclic neuropeptide made mainly by neurons of the lateral hypothalamus. In 1999 two groups identified MCH as the ligand of an orphan receptor, now called MCHR1 or G protein-coupled receptor 24 (GPR24). Mice lacking MCH were hypophagic and lean in a 1998 study, which linked the peptide to feeding and energy balance. Antagonists are used in rodent models of food intake, body weight, anxiety and mood. SNAP 94847, NGD-4715 and BMS-819881 are listed MCHR1 antagonists, together with ATC0065 and SB-568849.
Ethyl linolenate is a fatty acid ethyl ester that functions as a melanogenesis inhibitor. It effectively reduces melanin production in cells, exhibiting an IC50 of 70 μM. This compound is valuable in research applications focused on skin pigmentation and related disorders, as well as in the exploration of potential therapeutic agents for hyperpigmentation conditions.
BMS-814580 is a selective melanocortin receptor 1 (MCHR1) inhibitor with a Ki of 16.9 nM against human MCHR1. This compound demonstrates significant antiobesity effects, making it a valuable tool for research into metabolic disorders and weight management. BMS-814580 can be utilized in studies exploring the role of MCHR1 in energy homeostasis and therapeutic approaches to obesity.
